{
    "title": "MONEY MAIL: Profiting from ImmuPharma",
    "url": "https://www.dailymail.co.uk/money/article-1231550/MONEY-MAIL-Profiting-ImmuPharma.html",
    "date": "2009-11-27",
    "keywords": [
        "share",
        "drug",
        "time",
        "immupharma",
        "market",
        "decision",
        "price",
        "mail",
        "run",
        "week",
        "lupuzor",
        "investment",
        "gain",
        "stock",
        "phase",
        "information",
        "cephalon",
        "position",
        "miner",
        "cash",
        "profit",
        "shire",
        "money",
        "lyall",
        "mailonline",
        "gmt",
        "view",
        "record",
        "high",
        "update",
        "progress",
        "trailing",
        "january",
        "reason",
        "shouldnt",
        "recapture",
        "ground",
        "trial",
        "executive",
        "dimitri",
        "dimitriou",
        "assertion",
        "return",
        "immupharmas",
        "term",
        "uncertainty",
        "outlook",
        "company",
        "venture",
        "partner",
        "stage",
        "research",
        "peel",
        "patient",
        "fund",
        "article",
        "launch",
        "analyst",
        "cuddon",
        "target",
        "peak",
        "bid",
        "quantum",
        "copper",
        "tidy",
        "entry",
        "slide",
        "rule",
        "fq",
        "game",
        "town",
        "mix",
        "play",
        "sector",
        "summer",
        "success",
        "quarter",
        "performance",
        "pharma",
        "bank",
        "foray",
        "year",
        "portfolio",
        "advance",
        "ftse",
        "end",
        "december",
        "intact"
    ],
    "category": [
        "money"
    ]
}